Inventor · disambiguated record
Songliang Wu
Also filed as: WU SONGLIANG
8 granted patents·6 citations·filing 2015–2020
76Inventor score
Top patents by PatentIndex Score
8 records- 0182US10100047B2Piperidine derivatives as orexin receptor antagonistSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Oct 16, 2018·5 cites·10 claims
- 0270US10981860B2Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Apr 20, 2021·1 cites·18 claims
- 0367US10912775B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Feb 9, 2021·0 cites·7 claims
- 0465US10874674B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Dec 29, 2020·0 cites·5 claims
- 0564US10898486B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Jan 26, 2021·0 cites·6 claims
- 0653US10668066B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2016·Granted Jun 2, 2020·0 cites·7 claims
- 0744US11091450B2Crystal of a caspase inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Aug 17, 2021·0 cites·19 claims
- 0841US11434212B2Bicyclic compound as a caspase inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Sep 6, 2022·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Songliang Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →